View Item 

Show simple item record

Disparities in risk perception of thyroid cancer recurrence and death
dc.contributor.authorChen, Debbie W.
dc.contributor.authorReyes‐gastelum, David
dc.contributor.authorWallner, Lauren P.
dc.contributor.authorPapaleontiou, Maria
dc.contributor.authorHamilton, Ann S.
dc.contributor.authorWard, Kevin C.
dc.contributor.authorHawley, Sarah T.
dc.contributor.authorZikmund‐fisher, Brian J.
dc.contributor.authorHaymart, Megan R.
dc.date.accessioned2020-03-17T18:27:41Z
dc.date.availableWITHHELD_14_MONTHS
dc.date.available2020-03-17T18:27:41Z
dc.date.issued2020-04-01
dc.identifier.citationChen, Debbie W.; Reyes‐gastelum, David ; Wallner, Lauren P.; Papaleontiou, Maria; Hamilton, Ann S.; Ward, Kevin C.; Hawley, Sarah T.; Zikmund‐fisher, Brian J. ; Haymart, Megan R. (2020). "Disparities in risk perception of thyroid cancer recurrence and death." Cancer (7): 1512-1521.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/154276
dc.publisherWiley
dc.subject.otherthyroid cancer
dc.subject.otherquality of life
dc.subject.othermortality
dc.subject.otherHispanics
dc.subject.otherhealth care disparities
dc.subject.otherrecurrence
dc.titleDisparities in risk perception of thyroid cancer recurrence and death
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154276/1/cncr32670.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154276/2/cncr32670_am.pdf
dc.identifier.doi10.1002/cncr.32670
dc.identifier.sourceCancer
dc.identifier.citedreferenceGroves RM, Fowler FJ, Couper MP, Lepkowski JM, Singer E, Tourangean R. Survey Methodology. 2nd ed. Wiley; 2009.
dc.identifier.citedreferenceHaugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26: 1 â 133.
dc.identifier.citedreferenceBanerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR. Treeâ based model for thyroid cancer prognostication. J Clin Endocrinol Metab. 2014; 99: 3737 â 3745.
dc.identifier.citedreferenceTuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer/Tumorâ Nodeâ Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): what changed and why? Thyroid. 2017; 27: 751 â 756.
dc.identifier.citedreferenceAmerican Cancer Society. Thyroid cancer survival rates, by type and stage. Accessed February 20, 2017. https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/survival-rates.html
dc.identifier.citedreferenceHedman C, Djarv T, Strang P, Lundgren CI. Determinants of longâ term quality of life in patients with differentiated thyroid carcinomaâ a populationâ based cohort study in Sweden. Acta Oncol. 2016; 55: 365 â 369.
dc.identifier.citedreferenceSchultz PN, Beck ML, Stava C, Vassilopoulouâ Sellin R. Health profiles in 5836 longâ term cancer survivors. Int J Cancer. 2003; 104: 488 â 495.
dc.identifier.citedreferenceHoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JW. Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2008; 93: 200 â 203.
dc.identifier.citedreferenceMalterling RR, Andersson RE, Falkmer S, Falkmer U, Nilehn E, Jarhult J. Differentiated thyroid cancer in a Swedish countyâ longâ term results and quality of life. Acta Oncol. 2010; 49: 454 â 459.
dc.identifier.citedreferenceDillman DA, Smyth JD, Christian LM. Internet, Mail, and Mixedâ Mode Surveys: The Tailored Design Method. 3rd ed. Wiley; 2009.
dc.identifier.citedreferenceAmerican Association for Public Opinion Research. Response ratesâ an overview. Accessed February 20, 2017. https://www.aapor.org/Education-Resources/For-Researchers/Poll-Survey-FAQ/Response-Rates-An-Overview.aspx
dc.identifier.citedreferenceTuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010; 20: 1341 â 1349.
dc.identifier.citedreferenceYoung JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA. SEER Summary Staging Manualâ 2000: Codes and Coding Instructions. National Cancer Institute; 2001. NIH publication 01â 4969.
dc.identifier.citedreferenceLee KL, Janz NK, Zikmundâ Fisher BJ, et al. What factors influence women’s perceptions of their systemic recurrence risk after breast cancer treatment? Med Decis Making. 2018; 38: 95 â 106.
dc.identifier.citedreferenceJanz NK, Hawley ST, Mujahid MS, et al. Correlates of worry about recurrence in a multiethnic populationâ based sample of women with breast cancer. Cancer. 2011; 117: 1827 â 1836.
dc.identifier.citedreferenceJanz NK, Friese CR, Li Y, Graff JJ, Hamilton AS, Hawley ST. Emotional wellâ being years postâ treatment for breast cancer: prospective, multiâ ethnic, and populationâ based analysis. J Cancer Surviv. 2014; 8: 131 â 142.
dc.identifier.citedreferenceJanz NK, Li Y, Beesley LJ, et al. Worry about recurrence in a multiâ ethnic population of breast cancer survivors and their partners. Support Care Cancer. 2016; 24: 4669 â 4678.
dc.identifier.citedreferenceHealthMeasures. Patientâ Reported Outcomes Measurement Information System. Accessed February 20, 2017. http://www.healthmeasures.net/explore-measurement-systems/promis
dc.identifier.citedreferenceHawley ST, Janz NK, Griffith KA, et al. Recurrence risk perception and quality of life following treatment of breast cancer. Breast Cancer Res Treat. 2017; 161: 557 â 565.
dc.identifier.citedreferenceJagsi R, Pottow JA, Griffith KA, et al. Longâ term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through populationâ based registries. J Clin Oncol. 2014; 32: 1269 â 1276.
dc.identifier.citedreferenceAdamo M, Dickie L, Ruhl J. 2014 SEER Program Coding and Staging Manual. National Cancer Institute; 2014.
dc.identifier.citedreferencePapaleontiou M, Reyesâ Gastelum D, Gay BL, et al. Worry in thyroid cancer survivors with a favorable prognosis. Thyroid. 2019; 29: 1080 â 1088.
dc.identifier.citedreferenceKish L. Survey Sampling. John Wiley & Sons Inc; 1965.
dc.identifier.citedreferenceRutherford EJ, Kelly J, Lehane EA, et al. Health literacy and the perception of risk in a breast cancer family history clinic. Surgeon. 2018; 16: 82 â 88.
dc.identifier.citedreferenceLipkus IM, Peters E, Kimmick G, Liotcheva V, Marcom P. Breast cancer patients’ treatment expectations after exposure to the decision aid program Adjuvant Online: the influence of numeracy. Med Decis Making. 2010; 30: 464 â 473.
dc.identifier.citedreferenceSosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998; 228: 320 â 330.
dc.identifier.citedreferenceSosa JA, Mehta PJ, Wang TS, Yeo HL, Roman SA. Racial disparities in clinical and economic outcomes from thyroidectomy. Ann Surg. 2007; 246: 1083 â 1091.
dc.identifier.citedreferenceShah SA, Adam MA, Thomas SM, et al. Racial disparities in differentiated thyroid cancer: have we bridged the gap? Thyroid. 2017; 27: 762 â 772.
dc.identifier.citedreferenceKelly KM, Ajmera M, Bhattacharjee S, et al. Perception of cancer recurrence risk: more information is better. Patient Educ Couns. 2013; 90: 361 â 366.
dc.identifier.citedreferenceRondanina G, Puntoni M, Guerrieriâ Gonzaga A, Marra D, Bonanni B, DeCensi A. Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users. Breast. 2017; 34: 108 â 114.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr32670.pdf
Size:
732.2KB
Format:
PDF
View/Open
Name:
cncr32670_am.pdf
Size:
366.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.